Rigel Pharmaceuticals
RIGL
#7539
Rank
NZ$0.53 B
Marketcap
$30.28
Share price
-0.70%
Change (1 day)
51.27%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2024 (TTM): NZ$17.94 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.15 Billion. In 2023 the company made an earning of -NZ$32.29 Million, an increase over its 2022 earnings that were of -NZ$97.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$17.94 M-155.59%
2023 -NZ$32.29 Million-66.79%
2022 -NZ$97.22 Million340.73%
2021 -NZ$22.06 Million-56.15%
2020 -NZ$50.31 Million-57.34%
2019 -NZ$0.12 Billion-7.66%
2018 -NZ$0.13 Billion-9.47%
2017 -NZ$0.15 Billion24.46%
2016 -NZ$0.12 Billion23.63%
2015 -NZ$91.68 Million-43.29%
2014 -NZ$0.17 Billion2.5%
2013 -NZ$0.16 Billion
2010 NZ$67.07 M-133.97%
2009 -NZ$0.2 Billion-18.49%
2008 -NZ$0.25 Billion71.91%
2007 -NZ$0.15 Billion84.74%
2006 -NZ$76.28 Million-10.17%
2005 -NZ$84.91 Million-15.73%
2004 -NZ$0.11 Billion39.29%
2003 -NZ$72.34 Million10.3%
2002 -NZ$65.59 Million48.3%
2001 -NZ$44.23 Million-2.13%
2000 -NZ$45.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.24 Billion-1,211.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.24 Billion-1,242.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.08 B 81,961.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$8.29 B 39,717.89%๐Ÿ‡บ๐Ÿ‡ธ USA